Home Products & Services Panels MRD AML

MRD AML Panel

Advance your understanding of the clonal heterogeneity and evolution underpinning acute myeloid leukemia (AML) measurable residual disease (MRD) by targeting 41 genes with 323 amplicons for single-cell sequencing. Curated based on input from global key opinion leaders in acute myeloid leukemia and international guidelines such as the European LeukemiaNet (ELN) for AML MRD and the International Consensus Classification (ICC) for myeloid neoplasms, this panel covers the most commonly mutated hotspots in AML MRD. This panel has been verified in a wet lab to meet performance specifications.

REQUEST A QUOTE

Panel Details

Tapestri Single-cell DNA MRD AML Panel

Advance your understanding of the genetic heterogeneity underpinning AML MRD by targeting 41 genes with 323 amplicons for single-cell DNA sequencing. This panel has been verified in a wet lab to meet performance specifications.

DOWNLOAD DATASHEET

View and download panel content and coordinates using Tapestri Designer

Want to modify this panel?

Use Tapestri Designer to add or remove content from existing catalog panels and make this panel your own with content that is relevant to your research. Or start from scratch and upload your human (hg19) or mouse (mm10) targets using gene names, genomic coordinates, or SNV IDs. Target anywhere in the whole human or mouse genome and advance your research with targeted single-cell DNA sequencing.

DESIGN PANEL